Lumentum Holdings Inc.: Form 10-Q for the period ended Oct 1, 2022
Filed with the SEC on Nov 8, 2022 and accepted by EDGAR at Nov 8, 2022, 14:32 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2022-10-01. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Gross profit | 3 months2022-07-03 to 2022-10-01 | $201.2m | us-gaap:GrossProfit |
| Research and development | 3 months2022-07-03 to 2022-10-01 | $72.7m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2022-07-03 to 2022-10-01 | $105.7m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2022-07-03 to 2022-10-01 | $13.5m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2022-07-03 to 2022-10-01 | $8.5m | us-gaap:InterestExpense |
| Income tax | 3 months2022-07-03 to 2022-10-01 | $19.2m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2022-07-03 to 2022-10-01 | −$400.0k | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2022-07-03 to 2022-10-01 | −$0.01 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2022-07-03 to 2022-10-01 | −$0.01 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2022-07-03 to 2022-10-01 | 68,100,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months2022-07-03 to 2022-10-01 | $20.8m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months2022-07-03 to 2022-10-01 | $22.9m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 3 months2022-07-03 to 2022-10-01 | $35.8m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2022-10-01 | $605.3m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2022-10-01 | $2.44bn | us-gaap:AssetsCurrent |
| Total assets | At period end2022-10-01 | $4.39bn | us-gaap:Assets |
| Current liabilities | At period end2022-10-01 | $802.8m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2022-10-01 | $2.86bn | us-gaap:Liabilities |
| Long-term debt | At period end2022-10-01 | $1.90bn | us-gaap:LongTermDebtNoncurrent |
| Short-term borrowings | At period end2022-10-01 | $420.2m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2022-10-01 | $1.53bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001628280-22-028783. Last ingested by Listed: Oct 24, 2026, 15:07 ET. Listed shows no prices and gives no investment advice.